2022
DOI: 10.1186/s12936-022-04287-3
|View full text |Cite
|
Sign up to set email alerts
|

Molecular screening reveals non-uniform malaria transmission in western Kenya and absence of Rickettsia africae and selected arboviruses in hospital patients

Abstract: Background In sub-Saharan Africa, malaria is the common diagnosis for febrile illness and related clinical features, resulting in the under-diagnosis of other aetiologies, such as arboviruses and Rickettsia . While these may not be significant causes of mortality in malaria-endemic areas, they affect the daily life and performance of affected individuals. It is, therefore, important to have a clear picture of these other aetiologies to institute correct diagnoses at hosp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 69 publications
0
2
0
Order By: Relevance
“…1 , 2 , 3 , 4 , 5 In turn, vector species involved in the transmission of ML parasites and arboviruses have different habits and environmental conditions in the development of their biological cycle. 1 , 5 , 7 Therefore, it should be added that transmission may be related to the individual’s place of residence, as well as their work activities, such as mining, deforestation, hunting, and fishing. 29 , 30 , 31…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…1 , 2 , 3 , 4 , 5 In turn, vector species involved in the transmission of ML parasites and arboviruses have different habits and environmental conditions in the development of their biological cycle. 1 , 5 , 7 Therefore, it should be added that transmission may be related to the individual’s place of residence, as well as their work activities, such as mining, deforestation, hunting, and fishing. 29 , 30 , 31…”
Section: Discussionmentioning
confidence: 99%
“…However, there are no vaccines or drugs available for CHIKV and ZIKV, and clinicians rely on supportive therapy, while for YFV a vaccine is recommended solely in the case of populations living in endemic areas. 1 , 6 , 7 , 8 , 9 Furthermore, for DENV, two vaccines are available to the population: Dengvaxia (Sanofi Pasteur), since 2022, 10 and QDENGA (Takeda), since 2023. 11 …”
mentioning
confidence: 99%